Protocols for the treatment of human tumor xenografts with camptothecins

被引：16

作者：

Giovanella, BC

Natelson, E

Harris, N

Vardeman, D

Stehlin, JS

机构：

来源：

CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT | 1996年 / 803卷

关键词：

D O I：

10.1111/j.1749-6632.1996.tb26387.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：181 / 187

页数：7

共 15 条

[1]

DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS [J].

GIOVANELLA, BC ;

STEHLIN, JS ;

WALL, ME ;

WANI, MC ;

NICHOLAS, AW ;

LIU, LF ;

SILBER, R ;

POTMESIL, M .

SCIENCE, 1989, 246 (4933) :1046-1048

[2]

GIOVANELLA BC, 1991, CANCER RES, V51, P3052

[3]

HINZ HR, 1994, CANCER RES, V54, P3096

[4]

KINGSBURY WC, 1991, J MED CHEM, V35, P98

[5]

KUNIMOTO T, 1987, CANCER RES, V47, P5944

[6]

DIFFERENTIAL INTERACTIONS OF CAMPTOTHECIN LACTONE AND CARBOXYLATE FORMS WITH HUMAN BLOOD COMPONENTS [J].

MI, ZH ;

BURKE, TG .

BIOCHEMISTRY, 1994, 33 (34) :10325-10336

[7]

MARKED INTERSPECIES VARIATIONS CONCERNING THE INTERACTIONS OF CAMPTOTHECIN WITH SERUM ALBUMINS - A FREQUENCY-DOMAIN FLUORESCENCE SPECTROSCOPIC STUDY [J].

MI, ZH ;

BURKE, TG .

BIOCHEMISTRY, 1994, 33 (42) :12540-12545

[8]

MOERTEL CG, 1972, CANCER CHEMOTH REP 1, V56, P95

[9]

MUGGIA FM, 1972, CANCER CHEMOTH REP 1, V56, P515

[10]

PANTAZIS P, 1993, CANCER RES, V53, P1577

← 1 2 →